Navigation
Navigation

News

Why we invested in Gradyent — AI for district heating

News
- 05/08/2020

Earlier this summer, we announced our first investment out of the Capricorn Digital Growth Fund. Together with Helen Ventures and Energiiq we committed €1.9 million to Gradyent, a Netherlands based venture actively helping utility companies…

Read more

Indigo Diabetes concludes a €38 million round of financing

News
- 27/07/2020

Indigo Diabetes concludes a €38 million round of financing to advance development of ground-breaking sensor for diabetes Second investment of the Capricorn Digital Growth Fund Invisible sensor for people with diabetes aims at measuring multiple…

Read more

Mainstay Medical announces US FDA approval of ReActiv8® Neurostimulation System for Chronic Low Back Pain

News
- 22/06/2020

U.S. commercialization expected to begin in the first half of 2021 Continues positive momentum for Mainstay, with increasing commercial footprint in Europe and expected launch in Australia in early 2021 Dublin, Ireland: 22 June 2020…

Read more

Illumina announced the acquisition of Bluebee, a portfolio company of both Capricorn ICT Arkiv and Quest for Growth

News
- 18/06/2020

Leuven, Belgium: 18 June 2020 - The announced transaction is the third successful exit of Capricorn ICT Arkiv. In 2015, Capricorn ICT Arkiv realised the successful exit of its investment in Cartagenia and in 2018 of…

Read more

Capricorn Digital Growth Fund announces first investment in Dutch AI company Gradyent while also adding new investors bringing the total fund size over € 50 million

News
- 16/06/2020

Leuven, Belgium: 16 June 2020 – Capricorn Partners announced today the intermediary closing of its Capricorn Digital Growth Fund bringing commitments to over € 50 million. At the same time the fund closed its first…

Read more

Confo Therapeutics expands Board with appointment of Rob Scott as Independent Director

News
- 10/06/2020

Ghent, Belgium: 10 June 2020 - Confo Therapeutics today announced the addition of a new member to its Board of Directors with the appointment of Rob Scott, MD, as an Independent Director. Dr Scott’s career…

Read more

Mainstay Medical announces reimbursement approval for ReActiv8 in Australia

News
- 08/06/2020

Dublin, Ireland: 8 June 2020 - Mainstay Medical Holdings plc today announced that ReActiv8, its implantable restorative neurostimulation system to treat disabling Chronic Low Back Pain, has been approved for inclusion in the Prostheses List…

Read more

Confo Therapeutics appoints Paolo Vicini as Chief Development Officer

News
- 03/06/2020

New management role underscores Company’s commitment to establishing and advancing its proprietary pipeline of GPCR modulating drug candidates Ghent, Belgium: 3 June 2020 – Confo Therapeutics today announced the appointment of Paolo Vicini, PhD, MBA,…

Read more

Seventure Partners joins ViroVet in series B funding

News
- 28/05/2020

Animal health company focused on combatting viral infections in livestock Leuven, Belgium: 28 May 2020 — ViroVet NV, a leading Belgian biopharmaceutical company active in the development of innovative vaccines and antiviral drugs for livestock,…

Read more

icometrix nv appoints Dr Steve Rietiker as Chairman of the board

News
- 26/05/2020

Leuven, Belgium and Chicago IL, USA: 26 May 2020 – icometrix, the world leader in software solutions for extracting clinically meaningful data from brain scans using artificial intelligence (AI), is proud to announce that Dr.…

Read more

VOID Technologies raises £6 million in investment

News
- 26/05/2020

Leuven, Belgium: 26 Mai 2020 - VOID Technologies Ltd. (VOID) has announced that it has raised £6 million in a funding round led by two investors: SABIC Ventures B.V., a subsidiary of SABIC, ranked as…

Read more

TruGenomix Partners with BlueBee to create the next generation Behavioral Science Data Ecosystem

News
- 20/05/2020

Rockville, MD and San Mateo, CA USA: 20 May 2020 – The unprecedented COVID-19 crisis has unleashed global emotional trauma that is rapidly evolving into a mental health pandemic within the pandemic. While post-traumatic stress…

Read more

icometrix welcomes Jennifer Young as Chief Commercial Officer

News
- 08/05/2020

Leuven, Belgium/Chicago IL, USA: 8 May 2020 – icometrix, the world leader in software solutions for extracting clinically meaningful data from brain scans using artificial intelligence (AI), is proud to announce that Jennifer Young has…

Read more

iSTAR Medical announces outstanding results with MIGS implant

News
- 29/04/2020

Two-year final results from STAR-I trial and initial data from STAR-II European trial tout MINIjectTM as a highly promising treatment. Wavre, Belgium: 29 April 2020 – iSTAR Medical SA, a clinical-stage medical device company pioneering…

Read more

icometrix launches the first CE-marked image AI solution for chest CT in COVID-19

News
- 23/04/2020

Leuven, Belgium: 23 April 2020 – icometrix, VUB, UZ Brussel, KU Leuven, UZ Leuven, and UZ Antwerpen, together with hospitals and organizations worldwide, joined forces in a global initiative to leverage artificial intelligence (AI) in…

Read more

Nexstim reports promising clinical outcomes of first 55 patients completing SmartFocus® rTMS treatment of Major Depressive Disorder

News
- 17/04/2020

Helsinki, Finland: 17 April 2020 – Nexstim Plc (NXTMH:HEX, NXTMS:STO) reports the clinical outcomes of the first 55 patients who have completed SmartFocus® rTMS therapy for treatment of major depressive disorder (MDD) at clinical sites…

Read more

ViroVet to support COVID19 research and sample testing

News
- 23/03/2020

Leuven, Belgium: 23 March 2019 – Belgian biotechnology company ViroVet announced today that it has made its expertise, research staff as well as part of its research facility available to support COVID19 research and sample…

Read more

icometrix early launching icompanion.ms

News
- 20/03/2020

Leuven, Belgium: 20 March 2020 – Wim Van Hecke, CEO of icometrix, announces: “In the light of the COVID-19 outbreak, our team is dedicated to supporting people with Multiple Sclerosis as well as we can!…

Read more

Capricorn Partners invests in plant-based protein company Prolupin

News
- 17/03/2020

Leuven, Belgium: 17 March 2020 - Capricorn Partners participates in a double-digit million growth financing round for Prolupin GmbH with an investment of € 7 million from its Capricorn Sustainable Chemistry Fund and Quest for Growth.…

Read more

Nexstim Plc financial statements release 2019

News
- 28/02/2020

Helsinki, Finland: 28 February 2020 – Nexstim Plc (NXTMH:HEX, NXTMS:STO), today provides its financial statements for the full year 2019 (1 January–31 December 2019) and H2 2019 (1 July-31 December 2019). Highlights, July – December…

Read more

Confo Therapeutics to present at Cowen 40th Annual Health Care Conference

News
- 27/02/2020

Ghent, Belgium: 27 February 2020 – Confo Therapeutics, a pioneering biopharma company, today announces that Cedric Ververken, CEO, will present at the Cowen 40th Annual Health Care Conference on Tuesday, March 3, 2020 at 3:00…

Read more

PREDICT-LAA trial enrolls first patient

News
- 17/01/2020

Ghent, Belgium: 17 January 2020 – FEops, a leader in personalized predictive planning for structural heart interventions, is proud to announce that today the first patient has been enrolled in the physician-initiated PREDICT-LAA trial. The…

Read more

Sequana Medical announces first-in-human data of Direct Sodium Removal (DSR) therapy published in Circulation

News
- 10/01/2020

Positive pre-clinical and clinical proof-of-concept data of Sequana Medical’s innovative DSR therapy published in top tier peer-reviewed cardiovascular journal Data demonstrates potential for treatment of volume overload due to heart failure Ghent, Belgium: 10 January…

Read more

Sequana Medical announces first patient enrolled in RED DESERT – REpeated Dose alfapump® DSR study for Treatment of diuretic-resistant heart failure patients

News
- 07/01/2020

The study aims to: Evaluate the safety of alfapump DSR in patients with heart failure Assess the feasibility of alfapump DSR to remove excess sodium and fluid from the body Explore the potential impact of…

Read more

FEops Awarded Euro 3.2 Million Grant From EU

News
- 10/12/2019

Ghent, Belgium: 10 December 2019 - FEops, a leader in personalized predictive planning for structural heart interventions, has been awarded a grant of Euro 3.2 million from the European Innovation Council (EIC) accelerator programme. “We…

Read more

Mainstay Medical announces regulatory approval from Australian Therapeutic Goods Administration (TGA) for ReActiv8

News
- 06/12/2019

Next step is applying for inclusion on Australian Prostheses List for private reimbursement; decision expected in the third quarter of 2020. Dublin, Ireland: 6 December 2019 – Mainstay Medical International plc (Euronext Paris: MSTY.PA and…

Read more

Nexstim Plc: Health Canada grants Nexstim NBT® Medical Device License for Canada

News
- 05/12/2019

Helsinki, Finland: 5 December 2019 – Nexstim Plc (NXTMH:HEX, NXTMS:STO) announces that its NBT® System with SmartFocus® TMS technology has received a medical device license from Health Canada. The medical device license allows Nexstim to…

Read more

Confo Therapeutics reports grant of two key patents for ConfoBodies™

News
- 02/12/2019

Ghent, Belgium: 2 December 2019 – Confo Therapeutics, a pioneering biopharma company, today announces that it has been granted two key ConfoBodyTM patents derived from the patent estate known as the “Steyaert patents”. The Steyaert…

Read more

Nexstim Plc: Shares subscribed for in the directed share issue have been registered

News
- 18/11/2019

Helsinki, Finland: 18 November 2019 – Nexstim Plc (NXTMH:HEX, NXTMS:STO) announced on 15 November 2019 that an aggregate of 15,687,350 new shares of Nexstim were subscribed for in the directed share issue. Such new shares…

Read more

Dr Leena Niemistö starts as new Chair of the Board of Nexstim Plc

News
- 11/11/2019

Helsinki, Finland: 11 November 2019 – Nexstim Plc (NXTMH:HEX, NXTMS:STO) announces that the Extraordinary General Meeting of Shareholders has elected Leena Niemistö as the new Chair of the Board of Directors. Niemistö has distinguished experience…

Read more

Nexstim has placed an NBT® System with SmartFocus® technology to Stanford University Medical Center

News
- 14/10/2019

Helsinki, Finland: 14 October 2019 – Nexstim Plc (NXTMH:HEX, NXTMS:STO) – the company developing and marketing a unique brain stimulation technology for personalized treatment of major depressive disorder (MDD) – announces that it has placed…

Read more

BlueBee establishes data center in mainland China, expanding global coverage for its Genomics Data Platform

News
- 09/10/2019

Rijswijk, The Netherlands: 9 October 2019 – BlueBee, a global bioinformatics solutions provider, has extended data operations to mainland China to serve genomic data processing needs in compliance with The Chinese Ministry of Health and…

Read more

Mainstay Medical announces acceptance for filing by US FDA of Pre-Market Approval (PMA) Application for ReActiv8

News
- 01/10/2019

Dublin, Ireland: 1 October 2019 – Mainstay Medical International plc (Euronext Paris: MSTY.PA and Euronext Growth of Euronext Dublin: MSTY.IE), a medical device company focused on bringing to market ReActiv8®, an implantable neurostimulation system to…

Read more

Nexstim New System Sales Update

News
- 27/09/2019

Helsinki, Finland: 27 September 2019 - Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company")—the company developing and marketing a unique brain stimulation technology for diagnostics and therapy—announces it has sold one NBS System and two NBT®…

Read more

Sequana Medical announces first patient enrolled in North American alfapump® pivotal study (POSEIDON)

News
- 25/09/2019

• Study aims to support the approval of the alfapump in U.S. and Canada • Results anticipated by mid-2021 • U.S. launch of the alfapump planned for H1 2022 Ghent, Belgium: 25 September 2019 –…

Read more

FierceBiotech names Confo Therapeutics as one of its “Fierce 15” Biotech Companies of 2019

News
- 23/09/2019

Ghent, Belgium: 23 September 2019 – Confo Therapeutics, a pioneering biopharma company, today announces that it has been named by FierceBiotech as one of 2019’s Fierce 15 biotechnology companies, designating it as one of the…

Read more

Menarini Silicon Biosystems launches the MSBiosuite Bioinformatic platform, partners with BlueBee cloud-based solution automates NGS data analysis for liquid biopsy and FFPE workflows

News
- 19/09/2019

Bologna, Italy: 19 September 2019 – Menarini Silicon Biosystems today announces the launch of the MSBiosuite, a cloud-based data analysis solution that completes the company workflow* for liquid biopsy and formalin-fixed paraffin embedded (FFPE) tissue…

Read more

Sequana Medical appoints leading experts as Heart Failure Scientific Advisors

News
- 19/09/2019

Dr Butler, Dr Costanzo, Dr Tang and Dr Testani to advise on alfapump® DSR development Ghent, Belgium: 19 September 2019 – Sequana Medical NV (Euronext Brussels: SEQUA), innovators in the management of fluid overload in…

Read more

iSTAR Medical announces € 40 million Series C financing

News
- 05/09/2019

To accelerate development and commercialisation of innovative Glaucoma MIGS device, MINIjectTM Wavre, Belgium: 5 September 2019 —iSTAR Medical SA, a private medical device company developing novel ophthalmic implants for the treatment of glaucoma, today announced…

Read more

Capricorn Venture Partners renamed to Capricorn Partners

News
- 30/08/2019

Leuven, Belgium: 30 August 2019 - As of today, Capricorn Partners is the new name of Capricorn Venture Partners. Capricorn Partners reflects better some recent changes in the structure of the company and the broader…

Read more

LindaCare partners with Philips

News
- 30/08/2019

LindaCare’s OnePulse combines with Philips’ IntelliSpace Cardiovascular informatics platform to streamline inhospital and remote follow-up care for patients with cardiac implantable electronic devices Leuven, Belgium, Stamford, USA: 28 August 2019 – prior to the European…

Read more

Nexstim NBT® system authorized for commercial distribution in Australia

News
- 05/08/2019

Helsinki, Finland: 5 August 2019 – Nexstim Plc (NXTMH:HEX, NXTMS:STO) - the targeted neuromodulation company developing and marketing pioneering navigated personalised, non-invasive brain stimulation systems for the treatment of major depressive disorder (MDD) - announces…

Read more

Mainstay Medical announces completion of financing transactions

News
- 30/07/2019

• Funds to be used to support PMA process for ReActiv8® in US and to further European commercial validation efforts •  Gross proceeds, together with savings from previously-announced debt restructuring, provides approximately $28 million in cash runway…

Read more

iSTAR Medical’s MINIject shows consistent results at 18-month follow-up in first-in-human trial (STAR-I)

News
- 10/07/2019

Wavre, Belgium: 10 July 2019 – iSTAR Medical SA, a private medical device company developing novel ophthalmic implants for the treatment of glaucoma, today announced consistent 18-month results of the first-in-human, micro-invasive glaucoma surgery (MIGS)…

Read more

DMC Biotechnologies announces first close of US$10.3M Series A financing led by Sofinnova Partners

News
- 09/07/2019

Boulder, CO, USA: 9 July 2019 – DMC, an early-stage biotechnology company, announced today that is has raised a Series A equity financing led by Sofinnova Partners. The company also announced the addition to its…

Read more

Second Nexstim NBT® system ordered by Island Psychiatry PC, US

News
- 03/07/2019

Helsinki, Finland: 3 July 2019 – Nexstim Plc (NXTMH:HEX, NXTMS:STO) - the targeted neuromodulation company developing and marketing pioneering navigated personalized, non-invasive brain stimulation systems for the treatment of Major Depressive Disorder (MDD) - announces…

Read more

Confo Therapeutics and DyNAbind announce drug discovery collaboration to identify novel GPCR-modulating compounds

News
- 03/07/2019

Ghent, Belgium, and Dresden, Germany: 3 July 2019 – Confo Therapeutics, an emerging drug discovery company, and DyNAbind GmbH today announce a drug discovery collaboration on an undisclosed G-protein coupled receptor (GPCR). The collaboration will…

Read more

First closing of Capricorn Digital Growth Fund at €48 million

News
- 28/06/2019

Leuven, Belgium: 28 June 2019 – Capricorn Venture Partners, the Leuven-based independent manager of venture capital and equity funds, announces the first closing of its latest initiative, the Capricorn Digital Growth Fund securing more than…

Read more

Arkite raises € 1.5 million to grow internationally

News
- 27/06/2019

Limburg's technology company wants to roll out its Human Interface Mate in Europe and Asia. Genk, Belgium: 27 June 2019 – The technology company Arkite, active in augmented reality technology that helps operators in production…

Read more

Finnish spinal cord injury rehabilitation research using Nexstim SmartFocus™ technology receives significant funding from Wings for Life Foundation

News
- 26/06/2019

Helsinki, Finland: 26 June 2019 – Nexstim Plc (NXTMH:HEX, NXTMS:STO), the targeted neuromodulation company developing and marketing navigated, personalised and non-invasive brain stimulation systems for diagnostics and therapy - today announces that Helsinki University Hospital…

Read more

Mainstay Medical announces completion of pre-submission meeting with FDA regarding Pre-Market Approval (PMA) application for ReActiv8

News
- 26/06/2019

Dublin, Ireland: 26 June 2019 – Mainstay Medical International plc (Euronext Paris: MSTY.PA and Euronext Growth operated by Euronext Dublin (MSTY.IE), a medical device company focused on bringing to market ReActiv8, an implantable restorative neurostimulation…

Read more

Confo Therapeutics receives €1.7 million grant from VLAIO to progress novel GPCR-modulating compounds for an orphan indication

News
- 20/06/2019

Ghent, Belgium: 20 June 2019 – Confo Therapeutics, an emerging drug discovery company, today announces that it has been awarded a €1.7 million grant from Flanders Innovation & Entrepreneurship (VLAIO). The grant will run over…

Read more

NGDATA enables marketers to design and deliver data-driven, individualised campaigns in minutes, not weeks – Intelligent Engagement Platform unlocks the power of personalisation for every marketer – no data science degree needed

News
- 18/06/2019

London, UK: 18 June 2019 - NGDATA today announces a new platform that transforms marketers’ ability to tailor campaigns to individual consumers, enabling them to set up data-rich, insight-driven customer campaigns in minutes rather than…

Read more

Leading Austrian Clinic, Klinik Pirawarth, Provides Positive Feedback on its First Nexstim NBT® System for Treatment of Depression and Pain

News
- 18/06/2019

Helsinki, Finland: 18 June 2019 - Nexstim Plc (NXTMH:HEX, NXTMS:STO), the targeted neuromodulation company developing and marketing pioneering navigated personalised, non-invasive brain stimulation systems for the treatment of Major Depressive Disorder (MDD) - announces that…

Read more

Nexstim NBS system sold to the Jewish General Hospital in Canada

News
- 28/05/2019

Helsinki, Finland: 28 May 2019 - Nexstim Plc (NXTMH:HEX, NXTMS:STO) - the targeted neuromodulation company developing and marketing pioneering, navigated, personalised, non-invasive brain stimulation systems for diagnostics and therapy - today announces that it has…

Read more

Sequana Medical announces presentation of positive DSR clinical proof-of-concept data demonstrating potential in volume overload due to heart failure

News
- 27/05/2019

Ghent, Belgium: 27 May 2019 – Sequana Medical NV (Euronext Brussels: SEQUA), a commercial stage medical device company focused on the development of innovative treatment solutions for the management of liver disease, heart failure, malignant…

Read more

Nexstim sells first NBT® system in Germany for depression therapy and research

News
- 22/05/2019

Helsinki, Finland: 22 May 2019 - Nexstim Plc (NXTMH:HEX, NXTMS:STO), the targeted neuromodulation company developing and marketing pioneering navigated personalised, non-invasive brain stimulation systems for the treatment of Major Depressive Disorder (MDD), announces that it…

Read more

Brain imaging AI leader icometrix raises US$ 18 million in new funding

News
- 13/05/2019

Company’s technology will transform care for patients with brain disorders and injuries Leuven, Belgium, Geneva, Switzerland, Boston, USA: 13 May 2019 − icometrix, the global expert in brain imaging Artificial Intelligence solutions, has raised $18…

Read more

Soitec expands its engineered substrate portfolio into GaN (Gallium Nitride) with the acquisition of EpiGaN nv

News
- 13/05/2019

Acquisition accelerates Soitec’s penetration across high-growth 5G, power and sensor market segments Bernin (Grenoble), France: May 13, 2019 - Soitec (Euronext Paris), an industry leader in designing and manufacturing innovative semiconductor materials, announced today that…

Read more

Nexstim enters depression therapy market in Sweden

News
- 10/05/2019

Helsinki, Finland: 10 May 2019 - Nexstim Plc (NXTMH:HEX, NXTMS:STO), the targeted neuromodulation company developing and marketing pioneering navigated personalised, non-invasive brain stimulation systems for the treatment of Major Depressive Disorder (MDD), announces that its…

Read more

Confo Therapeutics raises € 30 million in Series A financing

News
- 07/05/2019

Ghent, Belgium: 7 May 2019 - Confo Therapeutics, an emerging drug discovery company, today announces the completion of a € 30 million ($ 33.4 million) Series A financing. The investment was led by BioGeneration Ventures…

Read more

LindaCare builds Powerhouse Remote-Monitoring Team: two world-renowned cardiac implantable device experts join as Senior Physician Consultants

News
- 06/05/2019

Leuven, Belgium and Stamford , CT, USA: 6 May 2019 - LindaCare, a digital health company specializing in development of remote patient monitoring solutions for chronic disease management, announces at the Heart Rhythm Society Scientific…

Read more

Sequana Medical announces acceptance of late-breaking abstract of DSR therapy for volume overload in heart failure at Heart Failure 2019 Congress

News
- 30/04/2019

Ghent, Belgium: 30 April 2019 - Sequana Medical NV (Euronext Brussels: SEQUA), a commercial stage medical device company focused on the development of innovative treatment solutions for the management of liver disease, heart failure, malignant…

Read more

Professor Paul Fitzgerald joins Nexstim’s Scientific Advisory Board

News
- 24/04/2019

Helsinki, Finland: 24 April 2019 - Nexstim Plc (NXTMH:HEX, NXTMS:STO), the targeted neuromodulation company developing and marketing pioneering navigated personalized, non-invasive brain stimulation systems for the treatment of Major Depressive Disorder (MDD), today announces that…

Read more

Mainstay Medical provides company update and publishes 2018 full year results

News
- 18/04/2019

Dublin, Ireland: 18 April 2019 - Mainstay Medical International plc (Euronext Paris: MSTY.PA and Euronext Growth operated by Euronext Dublin (MSTY.IE), a medical device company focused on bringing to market ReActiv8, an implantable restorative neurostimulation…

Read more

FEops HEARTguideTM receives CE mark – not a joke

News
- 01/04/2019

Ghent, Belgium: 1 April 2019 - FEops, a leader in personalized predictive planning for structural heart interventions, today announced that FEops HEARTguideTM has received CE mark approval. FEops HEARTguideTM is a one-in-its-kind procedure planning environment…

Read more

LindaCare to debut ProPulse™ Cardiac Remote Monitoring Services

News
- 14/03/2019

Leuven, Belgium - Hartford, CT, USA: 14 March, 2019 - LindaCare, a digital health company specializing in remote patient monitoring solutions for chronic disease management, today announced the company will offer ProPulseTM, a new remote…

Read more

Bluebee receives Health Data Hosting (HDS) accreditation

News
- 09/03/2019

Rijswijk, The Netherlands: 6 March 2019 - Bluebee, a global bioinformatics solutions provider, has been awarded the HDS:2018 certification for its Information Security Management System (ISMS). The Hébergeurs de Données de Santé or Health Data…

Read more

Confo Therapeutics forms Scientific Advisory Board as it accelerates development of proprietary drug discovery engine

News
- 28/02/2019

Ghent, Belgium: 28 February 2019 - Confo Therapeutics, an emerging drug discovery company, today announces the formation of its Scientific Advisory Board (SAB) with four key appointments: Radu Aricescu, Peter Kolb, Graeme Milligan and Jan…

Read more

Nexstim Plc Depression Therapy Business Update

News
- 14/01/2019

Helsinki, Finland: 14 January 2019 - Nexstim Plc (NXTMH:HEX, NXTMS:STO), the targeted neuromodulation company developing and marketing pioneering navigated personalised, non-invasive brain stimulation systems for the treatment of Major Depression Disorder (MDD), has shifted its…

Read more

Capricorn Venture Partners holds final close of its Capricorn Sustainable Chemistry Fund at € 86.5 million adding new investors

News
- 07/01/2019

Leuven, Belgium: January 7, 2019 - Capricorn Venture Partners has successfully held the final closing of its Capricorn Sustainable Chemistry Fund ("CSCF") at € 86.5 million, adding over € 30 million to its committed capital.…

Read more

Nexstim Plc signs Canadian distribution agreement for its SmartFocus™ TMS systems with Canadian Health Solutions CHS

News
- 07/01/2019

Helsinki, Finland: 7 January 2019 - Nexstim Plc (NXTMH:HEX, NXTMS:STO), the targeted neuromodulation company developing and marketing pioneering navigated personalised, non-invasive brain stimulation systems for the treatment of Major Depression Disorder (MDD), announces it has…

Read more

Capricorn ICT Arkiv, Quest for Growth and Pamica invest in Leuven-based scale-up miaa Guard

News
- 03/01/2019

Leuven, Belgium: 3 January 2019 - Capricorn Venture Partners is investing both from the Capricorn ICT Arkiv as well as from Quest for Growth in a total round of € 3 million in miaa Guard,…

Read more

Confo Therapeutics announces exclusive, worldwide license agreement with VIB for Powerful Novel Structure Determination Technology

News
- 03/01/2019

Confo Therapeutics secures exclusive, worldwide license to new proprietary Megabody technology for GPCRs Megabody scaffold extends the utility of Confo® bodies to cryo-EM, without affecting their conformation selectivity Two Megabody publications in this week's issue…

Read more

iSTAR Medical’s MINIject maintains exceptional results in first-in-human trial one year post-surgery (STAR-I)

News
- 19/12/2018

Wavre, Belgium: 19 December 2018 - iSTAR Medical SA, a private medical device company developing novel ophthalmic implants for the treatment of glaucoma, today announced exceptional one-year results of the first-in-human, micro-invasive glaucoma surgery (MIGS)…

Read more

UK NICE recommends use of Sequana’s alfapump® for the treatment of refractory ascites caused by cirrhosis under special arrangements

News
- 15/11/2018

Ghent, Belgium: 15 November 2018 - Sequana Medical NV, a commercial stage medical device company focused on the development of innovative treatment solutions for the management of liver disease, heart failure, malignant ascites and other…

Read more

Sequana Medical announces the appointments of industry experts Pierre Chauvineau as Chairman and Wim Ottevaere as Non-Executive Director

News
- 08/11/2018

Ghent, Belgium: 8 November 2018 - Sequana Medical nv, a commercial stage medical device company focused on the development of innovative treatment solutions for the management of liver disease, heart failure, malignant ascites and other…

Read more

Capricorn’s Sustainable Chemistry Fund joins Black Bear funding round to solve the global waste tire problem and slash CO2

News
- 06/11/2018

The Dutch company Black Bear aims to scale up its unique "Tire to Carbon Black" technology: Each plant would prevent emissions equal to the CO2 captured by more than 1 million trees; It will use…

Read more

Nexstim secures Business Finland funding for the development of wireless EMG devices

News
- 25/10/2018

Helsinki, Finland: 25 October 2018 - Nexstim Plc (NXTMH:HEX, NXTMS:STO), the targeted neuromodulation company developing, and marketing pioneering navigated personalised, non-invasive brain stimulation systems for the treatment of Major Depression Disorder (MDD), announces today that…

Read more

Sequana Medical establishes new corporate headquarters in Ghent, Belgium and raises € 8.5 million from leading Belgian investors including Newton Biocapital, PMV and SFPI-FPIM as well as existing shareholders

News
- 15/10/2018

Ghent, Belgium: 15 October 2018 - Sequana Medical NV, a commercial stage medical device company focused on the development of innovative treatment solutions for the management of liver disease, heart failure, malignant ascites and other…

Read more

Varian Expands cancer care portfolio with Noona Healthcare acquisition

News
- 12/10/2018

Palo Alto CA, USA: 12 October 2018 - Varian (NYSE: VAR) today announced the acquisition of privately-held software company Noona Healthcare, developer of a cloud-based, mobile service designed to capture cancer patient-reported outcomes (PROs). The…

Read more

Nexstim Plc supports 10th International Symposium on Navigated Brain Stimulation in Neurosurgery and Neuromodulation

News
- 28/09/2018

Helsinki, Finland: 28 September 2018 - Nexstim Plc (NXTMH:HEX, NXTMS:STO), the targeted neuromodulation company developing and marketing pioneering navigated non-invasive brain stimulation systems for both therapeutic and diagnostic application, today announces its support for the…

Read more

Mainstay Medical announces 2018 half-year financial results and update

News
- 21/09/2018

Dublin, Ireland: 21 September 2018 – Mainstay Medical International plc (Euronext Paris: MSTY.PA and Euronext Dublin: MSTY.IE), a medical device company focused on commercializing ReActiv8®, an implantable restorative neurostimulation system designed to treat an underlying…

Read more

Nexstim Plc to present depression led strategy at Investor Conference Sijoittaja 2018 in Helsinki

News
- 19/09/2018

Helsinki, Finland: 19 September 2018 - Nexstim Plc (NXTMH:HEX, NXTMS:STO), the targeted neuromodulation company developing and marketing navigated personalised, non-invasive brain stimulation systems for the treatment of Major Depressive Disorder (MDD), announces that the company…

Read more

Sequana Medical announces presentation of pre-clinical proof of concept results of its Direct Sodium Removal (DSR) therapy for the management of volume overload in heart failure at the Annual Scientific Meeting of the Heart Failure Society of America (HFSA)

News
- 17/09/2018

Zurich, Switzerland: 17 September 2018 - Sequana Medical AG, a commercial stage medical device company focused on the development of innovative treatment solutions for the management of liver disease, heart failure, malignant ascites and other…

Read more

Sequana Medical reports positive data on use of the alfapump® in malignant ascites patients at the International Gynecologic Cancer Society

News
- 17/09/2018

Zurich, Switzerland: 17 September 2018 - Sequana Medical AG, a commercial stage medical device company focused on the development of innovative treatment solutions for the management of liver disease, heart failure, malignant ascites and other…

Read more

Capricorn Venture Partners leads financing round at c-LEcta and lays foundation for further corporate growth

News
- 04/09/2018

Leuven, Belgium: 4 September 2018 - Capricorn Venture Partners has lead a round of growth financing at c-LEcta, a leading biotechnology company focused on enzyme engineering and applications in regulated markets like food and pharma.…

Read more

Capricorn Venture Partners announces SCG as limited partner in the Capricorn Sustainable Chemistry Fund

News
- 23/08/2018

Bangkok, Thailand and Leuven, Belgium: 23 August 2018 - SCG Chemicals Co., Ltd, part of the Siam Cement Public Company Limited (SCG), one of the largest integrated petrochemical companies in Thailand and a key industry…

Read more

Mainstay Medical announces the appointment of Matthew Onaitis as Chief Financial Officer

News
- 20/08/2018

Dublin, Ireland: 20 August 2018 - Mainstay Medical International plc (Euronext Paris: MSTY.PA and Euronext Dublin: MSTY.IE), a medical device company focused on bringing to market ReActiv8®, an implantable restorative neurostimulation system to treat disabling…

Read more

Diagenode announces acquisition of Service Provider NXT-Dx to complement Epigenetics Assay Services

News
- 16/08/2018

Denville, USA and Liege, Belgium: 16 August 2018 - Diagenode today announced the acquisition of NXT-Dx, an established epigenetics service provider based in Gent, Belgium. NXT-Dx provides a broad variety of start-to-finish epigenetics services including…

Read more

Nexstim Plc half-yearly report 1 January – 30 June 2018 (Unaudited)

News
- 16/08/2018

Helsinki, Finland: 16 August 2018 - Highlights, January-June 2018 Nexstim delivered its first Navigated Brain Therapy (NBT®) system in the US for the treatment of Major Depressive Disorder (MDD) following Nexstim's successful launch of the…

Read more

NGDATA accepted into G-Cloud 10 Framework

News
- 30/07/2018

London, UK: 30 July 2018 - NGDATA, the leading company in digital transformation and customer data platforms, has announced that it has been accepted into the latest G-Cloud framework, G-Cloud 10, as an official provider…

Read more

Noona and Duke Medicine to launch large study on I-O therapies in Oncology

News
- 30/07/2018

Palo Alto CA, USA: 30 July 2018 - Noona Healthcare, a leading Oncology Decision Support platform, announced today the initiation of a collaboration with Duke University School of Medicine to assess the long-term impact of…

Read more

Sequana Medical announces the appointment of Kirsten Van Bockstaele as Chief Financial Officer

News
- 12/07/2018

Zurich, Switzerland: 12 July 2018 - Sequana Medical AG, a commercial stage medical device company focused on the development of innovative treatment solutions for the management of liver disease, heart failure, malignant ascites and other…

Read more

Mainstay Medical announces the completion of all implants in the ReActiv8-B Study

News
- 09/07/2018

Dublin, Ireland: 9 July 2018 - Mainstay Medical International plc (Euronext Paris: MSTY.PA and Euronext Dublin: MSTY.IE), a medical device company focused on bringing to market ReActiv8, an implantable restorative neurostimulation system to treat disabling…

Read more

Green Biologics announces launch of first bio-based acetone nail polish remover to be introduced in Sally Beauty stores nationwide

News
- 25/06/2018

Little Falls, USA: 25 June 2018 - Green Biologics Inc. announced the commercial launch of the world's first bio-based acetone nail polish remover. Sally Beauty is the first retailer to carry the sustainably-produced nail polish…

Read more

Mainstay Medical appoints Wolfgang Frisch as VP and Managing Director for Germany

News
- 20/06/2018

Dublin, Ireland: 20 June 2018 - Mainstay Medical International plc ("Mainstay" or the "Company", Euronext Paris: MSTY.PA and Euronext Dublin: MSTY.IE), a medical device company focused on bringing to market ReActiv8®, an implantable restorative neurostimulation…

Read more

Bluebee achieves ISO 13485 Medical Device Quality Standard Certification

News
- 15/06/2018

Rijswijk, The Netherlands: 15 June 2018 - Bluebee, a global bioinformatics solutions provider, has announced today that it has been awarded the ISO 13485:2016 certification. ISO 13485 is an internationally recognized medical device quality management…

Read more

Lexogen and Bluebee collaborate to streamline QuantSeq-UMI Sequencing Data Analysis Pipeline

News
- 12/06/2018

Vienna, Austria and Rijswijk, The Netherlands: 12 June 2018 - Lexogen, a transcriptomics and next-generation sequencing company and Bluebee, a global bioinformatics platform, have announced today the implementation of QuantSeq Unique Molecular Identifiers (UMI) data…

Read more

Sensolus launches next generation tracking devices in cooperation with Jorjin Technologies Inc and STMicroelectronics

News
- 06/06/2018

Ghent, Belgium and, Taipei, Taiwan, and Labège, France: 6 June 2018 - To launch its next-generation Stickntrack tracking devices, Sensolus, an IoT company from Ghent, Belgium, is utilizing technology and expertise from Jorjin Technologies Inc.,…

Read more

Nexstim Plc – first NBT® system for depression ordered in the US

News
- 22/05/2018

Helsinki, Finland: 22 May 2018 - Nexstim Plc (NXTMH:HEX, NXTMS:STO), the targeted neuromodulation company developing and commercializing its world-leading navigated non-invasive brain stimulation technology for therapeutic and diagnostic applications, announces that it has agreed to…

Read more

iSTAR Medical’s MINIject delivers exceptional 6-month results

News
- 15/05/2018

Wavre, Belgium: 15 May 2018 - iSTAR Medical SA, a private medical device company developing novel ophthalmic implants for the treatment of glaucoma, today announced exceptional 6-month results of their first-in-human (FIH) micro-invasive glaucoma surgery…

Read more

Nexstim Plc launches NBT® system for depression at the US Clinical TMS Society Annual Meeting in New York

News
- 09/05/2018

Helsinki, Finland: 9 May 2018 - Nexstim Plc (NXTMH:HEX, NXTMS:STO) the targeted neuromodulation company developing and marketing pioneering navigated non-invasive brain stimulation systems for both therapeutic and diagnostic application, announces that it is launching its…

Read more

TCR signs Partnership Agreement with the Telematics’ Supplier Sensolus

News
- 12/04/2018

Brussels, Belgium: 12 April 2018 - TCR is proud to announce that it is launching a GSE TELEMATICS' SOLUTION for unmotorized Ground Support Equipment to the ground handling sector in partnership with the Belgian company…

Read more

Mainstay’s Update on Regulatory Application for ReActiv8 in Australia

News
- 05/04/2018

Dublin, Ireland: 5 April 2018 - Mainstay Medical International plc (Euronext Paris: MSTY.PA and ESM of the Irish Stock Exchange: MSTY.IE), a medical device company focused on bringing to market ReActiv8®, an implantable restorative neurostimulation…

Read more

NGDATA sets up global AI Research Lab in Singapore

News
- 04/04/2018

Singapore: 4 April 2018 - NGDATA®, the customer experience management solutions company, today announced that it has made significant investments to establish an Artificial Intelligence (AI) Research Lab in Singapore, the company's first research and…

Read more

Avantium announces 2017 results

News
- 28/03/2018

Amsterdam, the Netherlands: 28 March 2018 - Avantium N.V., (Euronext Amsterdam and Brussels: AVTX), a leading chemical technology company and forerunner in renewable chemistry, today reports 21% growth in revenues for 2017, strong demand for…

Read more

Green Biologics partners with Kingsford® Charcoal to launch new EcoLight™ natural charcoal lighter fluid

News
- 27/03/2018

Little Falls, USA: 27 March 2018 - Green Biologics, Inc announced that it has agreed to supply their patented GreenFlame® bio-based charcoal lighter fluid formulation exclusively to Kingsford® Charcoal, to be marketed under a new…

Read more

Sequana Medical announces publication of results of multicentre randomized controlled study

News
- 19/03/2018

Zurich, Switzerland: 19 March 2018 - Sequana Medical AG, a commercial stage medical device company and an innovator in the management of liver disease, announces the publication of a multicentre, randomized controlled study in Quality…

Read more

NGDATA named 2017 Tech Trailblazer for Big Data

News
- 21/02/2018

New York City, USA: 21 February 2018-NGDATA®, the customer experience management solutions company, today announced it was named the 2017 Tech Trailblazer Award winner in the Big Data category. LilyTM, the company's next-generation customer data…

Read more

Confo Therapeutics is awarded a € 1 million grant to increase its screening capabilities

News
- 20/02/2018

Ghent, Belgium: 20 February 2018 - Confo Therapeutics announced today that it has received a € 1 million grant from the Flemish Government through Flanders Innovation & Entrepreneurship (VLAIO). The grant will be used to…

Read more

Mainstay Medical announces € 30 million financing new capital to complete US Pivotal ReActiv8-B clinical study and advance european commercialization

News
- 15/02/2018

Dublin, Ireland: 15 February 2018 - Mainstay Medical International plc (Euronext Paris: MSTY.PA and ESM of the Irish Stock Exchange: MSTY.IE), a medical device company focused on bringing to market ReActiv8®, an implantable neurostimulation system…

Read more

Mainstay Medical publishes 2017 full year results

News
- 15/02/2018

Dublin, Ireland: 15 February 2018 - Mainstay Medical International plc (Euronext Paris: MSTY.PA and ESM of the Irish Stock Exchange: MSTY.IE), a medical device company focused on bringing to market ReActiv8, an implantable restorative neuro-stimulation…

Read more

FEops Elects Tom Fleming to its Board of Directors

News
- 15/02/2018

Ghent, Belgium: 15 February 2018 - FEops, a leader in personalized computational modelling and simulation for structural heart interventions, today announced that it has elected Tom Fleming to its board of directors, effective immediately. In…

Read more

New England Biolabs and Bluebee partner to deliver an end-to-end data analysis solution for NEBNext direct target enrichment

News
- 08/02/2018

Rijswijk, The Netherlands and Ipswich, USA: 8 February 2018 - Bluebee, a company driving global genomic data-driven medicine, and New England Biolabs, Inc. (NEB®) have partnered to provide a secure and convenient data processing solution…

Read more

Nexstim Plc receives R&D loan from Business Finland

News
- 23/01/2018

Helsinki, Finland: 23 January 2018 - Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company developing and marketing pioneering navigated non-invasive brain stimulation systems for both therapeutic and diagnostic applications, announces that Business Finland has granted…

Read more

Mainstay confirms its continued eligibility to the PEA-PME

News
- 23/01/2018

Dublin, Ireland: 23 January 2018 - Mainstay Medical International plc (listed on Euronext Paris: MSTY.PA and ESM of the Irish Stock Exchange: MSTY.IE) confirms today its continued eligibility to the PEA-PME (French equity savings plan…

Read more

NGDATA delivers smarter customer experiences and deeper insight with enhancements to the Lily Customer Data Platform

News
- 23/01/2018

New York City, USA: 23 January 2018 - NGDATA, the customer experience management solutions company, today announced enhancements to Lily, the company's next-generation customer data platform, designed to help marketers deliver more relevant customer experiences…

Read more

LindaCare raises € 7M funding to improve remote patient monitoring for chronic disease management

News
- 18/01/2018

Leuven, Belgium, Hartford CT, USA: 18 January 2018 - LindaCare, a digital health company specializing in remote patient monitoring solutions for chronic disease management, today announced a seven million Euro Series B investment, featuring participation…

Read more

ViroVet wins “start-up of the year” award

News
- 17/01/2018

Leuven, Belgium: 17 January 2018 - ViroVet NV, a leading Belgian biopharmaceutical company active in the development of innovative vaccines and antiviral drugs for livestock, is proud to announce that it has been presented with…

Read more

Avantium’s PEF pilot phase set to be extended

News
- 12/01/2018

Amsterdam, the Netherlands: 12 January 2018 - Avantium today announces that Synvina, its joint venture with BASF, plans to extend the pilot phase in order to optimize future commercial-scale production. Synvina has now completed a…

Read more

DMC Biotechnologies announces first close of $1.75M equity financing led by Capricorn

News
- 09/01/2018

Boulder CO, USA and Leuven, Belgium: 9 January 2018 - DMC (www.dmcbio.com), an early-stage biotechnology company, announced today that is has raised a first equity financing led by Capricorn Venture Partners. The company also announced…

Read more

Nexstim enrols last patient in supplementary Phase III E-FIT trial

News
- 06/01/2018

Helsinki, Finland: 6 January 2018 - Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company developing and marketing pioneering navigated non-invasive brain stimulation systems for both therapeutic and diagnostic applications, announces that it has successfully completed…

Read more

Agendia and Bluebee Partner to Bring New NGS-Based MammaPrint®BluePrint® Breast Cancer Kit to Market

News
- 19/12/2017

Irvine, USA and Rijswijk, Netherlands: 19 December 2017 - Agendia, Inc, a world leader in personalized medicine and molecular cancer diagnostics, and Bluebee, a company driving global genomic data-driven medicine, have partnered to provide a…

Read more

Confo Therapeutics enters into drug discovery collaboration with Roche

News
- 19/12/2017

Ghent, Belgium: 19 December 2017 - Confo Therapeutics, an emerging drug discovery company, announced today that it has entered into a research collaboration and license agreement with Roche for the discovery, development and commercialisation of…

Read more

Mainstay Medical announces positive outcome of interim analysis

News
- 11/12/2017

Dublin, Ireland: 11 December 2017 - Mainstay Medical International plc (Euronext Paris: MSTY.PA and ESM of the Irish Stock Exchange: MSTY.IE), a medical device company focused on bringing to market ReActiv8®, an implantable restorative neurostimulation…

Read more

Nexstim Plc has entered into an agreement on a financing arrangement that is conditional on the approval of the AGM

News
- 11/12/2017

Helsinki, Finland: 11 December 2017 - Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company developing and marketing pioneering navigated non-invasive brain stimulation systems for both therapeutic and diagnostic applications, announced in a company release published…

Read more

NGDATA raises US$ 19 million to fuel global growth

News
- 05/12/2017

New York City, USA: 5 December 2017- NGDATA®, the customer experience management solutions company, today announced that it has raised just over US$ 19 million in Series C funding. HPE Growth Capital led the round…

Read more

Kees Verhaar appointed as Chairman of Avantium’s Supervisory Board

News
- 01/12/2017

Amsterdam, the Netherlands: 1 December 2017 - Avantium N.V., (Euronext Amsterdam and Brussels: AVTX), a leading chemical technology company and forerunner in renewable chemistry, announces that today Mr Kees Verhaar has been appointed as Chairman…

Read more

Nexstim Plc appoints Steve Beller as Vice President and General Manager

News
- 01/12/2017

Helsinki, Finland: 1 December 2017 - Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company developing and marketing pioneering navigated non-invasive brain stimulation systems for both therapeutic and diagnostic applications, announces the appointment of Steve Beller…

Read more

Lexogen and Bluebee partner to bring the SLAMseq metabolic RNA sequencing data analysis pipeline to the users

News
- 10/11/2017

Rijswijk, The Netherlands and Vienna, Austria: 10 November 2017 - Bluebee, a company driving genomic data-driven medicine, and Lexogen a company enabling the analysis of the complete transcriptome, announce the successful integration of the SLAMdunk…

Read more

Nexstim raises € 1.75 million via a directed issue of new shares to London-based investor City Financial – Funds to be used to support beginning the commercialisation of its NBT® system

News
- 25/10/2017

Helsinki, Finland: 25 October 2017 - Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company developing and marketing pioneering navigated non-invasive brain stimulation systems for both therapeutic and diagnostic applications, announces that it is raising new…

Read more

Sequana Medical announces results of the MOSAIC trial data presented at 2017 AASLD

News
- 24/10/2017

Zurich, Switzerland: 24 October 2017 - Sequana Medical AG (Sequana Medical), a commercial stage medical device company and an innovator in the management of liver disease, today announced that Prof. Florence Wong, University of Toronto,…

Read more

Emmanuel Blin named Chairman of the Board at Noona Healthcare

News
- 19/10/2017

Helsinki, Finland: 19 October 2017 - Noona Healthcare has appointed Emmanuel Blin to the position of Chairman of the Board as of 18.10.2017. He will work closely with Noona management and board members to implement…

Read more

iSTAR Medical completes enrolment of first-in-human MIGS trial

News
- 17/10/2017

Wavre, Belgium: 17 October 2017 - iSTAR Medical SA, a private medical device company developing novel ophthalmic implants for the treatment of glaucoma, announced today the completion of enrolment in their first-in-human (FIH) micro-invasive glaucoma…

Read more

Nexstim Plc is negotiating an assembly and distribution arrangement in China and a financing arrangement for the financing of its bring-to-market strategy in Europe and the US

News
- 16/10/2017

Helsinki, Finland: 16 October 2017 - Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company developing and marketing pioneering navigated non-invasive brain stimulation systems for both therapeutic and diagnostic applications, is negotiating a potential assembly and…

Read more

Arkite raises € 1.6 million to accelerate its European expansion

News
- 16/10/2017

Genk, Belgium: 16 October 2017 - Arkite develops and markets the Human Interface Mate (HIM), an augmented reality technology to assist production operators. HIM uses a 3D sensor and a projector to inform, teach and…

Read more

PacBio and Bluebee launch de novo genome assembly pipeline on the Bluebee analysis platform

News
- 09/10/2017

Rijswijk, The Netherlands and Menlo Park, USA: 9 October 2017 - Bluebee, a company driving genomic data-driven medicine, and Pacific Biosciences of California, Inc. (NASDAQ: PACB), the leader in long-read sequencing, announced they have integrated…

Read more

Capricorn Venture Partners makes first investment from its Capricorn Sustainable Chemistry Fund and completes ViroVet’s series A funding

News
- 06/10/2017

Leuven, Belgium: 6 October 2017 - Capricorn Venture Partners is pleased to announce the first investment for its Capricorn Sustainable Chemistry Fund (CSCF). The fund has invested in ViroVet NV, a leading Belgian biopharmaceutical company…

Read more

FRX Polymers secures AU$ 15.15 million in pre-IPO mezzanine exchangeable notes

News
- 04/10/2017

Chelmsford, MA, USA: 4 October 2017 - FRX Polymers Inc, the global leader in polymeric halogen-free flame retardant solutions, announced that it has secured AU$ 15.15 million (approximately US$ 12 million) in pre-IPO mezzanine financing…

Read more

Sequana Medical announces publication of results of alfapump® Multicentre, Post-Marketing Surveillance Registry in Alimentary Pharmacology & Therapeutics (AP&T).

News
- 04/10/2017

Zurich, Switzerland: 4 October 2017 - Sequana Medical AG, a commercial stage medical device company and an innovator in the management of liver disease, announces the publication of "Treatment of refractory ascites with an automated…

Read more

Confo Therapeutics enters into drug discovery collaboration with Lundbeck

News
- 26/09/2017

Ghent, Belgium: 26 September 2017 - Confo Therapeutics, an emerging drug discovery company, today announced that it has entered into a drug discovery collaboration with H. Lundbeck A/S, a global pharmaceutical company specializing in psychiatric…

Read more

Ghent’s industrial Internet of Things company, Sensolus, raises € 2.75 million

News
- 26/09/2017

Ghent, Belgium: 26 September 2017 - Capricorn ICT Arkiv and Quest for Growth subscribed to a capital increase for the IoT company Sensolus. In addition to the current investors, an experienced entrepreneur also joined this…

Read more

FRX Polymers enables new high-impact strength, V-0 flame retardant, chemical-resistant thermoplastic compound from Polyvisions

News
- 25/09/2017

Manchester, PA, USA: 25 September 2017 - PolyVisions, a leading innovator and producer of thermoplastic compounded materials for industry, announced today the introduction of a durable, chemical-resistant, non-halogenated flame retardant (FR) material designed for demanding…

Read more

FEops closes € 6 million Series B financing

News
- 22/09/2017

Ghent, Belgium: 22 September 2017 - FEops, a leader in personalized computer modeling for structural heart interventions, announced it has secured a 6 million euros investment, led by Valiance, and joined by existing investors Capricorn…

Read more

FRX Polymers Announces Availability of Nofia® Non-Halogenated Flame Retardants as Replacement for Antimony in Brominated Systems

News
- 28/08/2017

Chelmsford, MA, USA: 28 August 2017 - FRX Polymers Inc, the global leader in polymeric halogen-free flame retardant solutions, has announced the availability of its Nofia® non-halogenated polyphosphonates as a replacement for antimony (ATO) in…

Read more

Changes in Nexstim Plc’s Management Team

News
- 03/08/2017

Helsinki, Finland: 3 August 2017 - Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company developing and marketing pioneering navigated non-invasive brain stimulation systems for both therapeutic and diagnostic applications, announces that Rainer Harjunpää has resigned…

Read more

Nexstim Plc Files 510(k) Submission for its NBT® system for the Treatment of Depression with US FDA

News
- 27/06/2017

Helsinki, Finland: 27 June 2017 - Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company developing and marketing pioneering navigated non-invasive brain stimulation systems for both therapeutic and diagnostic applications, is pleased to announce it filed…

Read more

Avantium included in Small Cap index Euronext

News
- 09/06/2017

Amsterdam, the Netherlands: 9 June 2017 - Avantium, a leading chemical technology company and forerunner in renewable chemistry announces that Avantium shares (symbol: AVTX) will be included in the AScX index of Euronext as of…

Read more

Avantium appoints Zanna McFerson as Chief Business Development Officer

News
- 08/06/2017

Amsterdam, the Netherlands: 8 June 2017 - Avantium, a leading chemical technology company and forerunner in renewable chemistry announces today it has appointed Mrs. Zanna McFerson as its Chief Business Development Officer. McFerson, former Chief…

Read more

Industry Consortium receives funds (€25 million) for polyethylenfuranoate (PEF)

News
- 08/06/2017

Amsterdam, the Netherlands: 8 June 2017 - Avantium proudly announces that a BBI subsidy of € 25 million has been granted to the Industry Consortium "PEFerence". The consortium, consisting of 11 companies including Synvina, Avantium,…

Read more

Bluebee and MediSapiens announce strategic partnership

News
- 29/05/2017

Finland and Rijswijk, The Netherlands: 29 May 2017 - Today, Bluebee, a leading provider of high-performance genomics analysis and storage solutions and MediSapiens, a leading biomedical big data curation, management and interpretation company, announce a…

Read more

New Chairman of the Board will accelerate US growth

News
- 23/05/2017

Leuven, Belgium/Hartford, Connecticut: 23 May 2017 - LindaCare is pleased to announce the appointment of Donald L. Deyo into the new role of Chairman of the Board, with immediate effect. Deyo is currently CEO of…

Read more

Nexstim Plc updates the timeline for its supplementary E-FIT Phase III Trial in Stroke Rehabilitation

News
- 17/05/2017

Helsinki, Finland: 19 May 2017 - Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company developing and marketing pioneering navigated non-invasive brain stimulation systems for both therapeutic and diagnostic applications, today provided a timeline update for…

Read more

NGDATA acquires Eccella to fuel international growth and expansion

News
- 16/05/2017

New  York, USA: 16 May 2017 -NGDATA, the customer experience management solutions company, today announced that it has signed a definitive agreement to acquire Eccella, a data management and analytics consultancy based in New York…

Read more

Aarhus University Hospital in Denmark purchases NBS System from Nexstim Plc

News
- 25/04/2017

Helsinki, Finland: 24 April 2017 - Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company developing and marketing pioneering navigated non-invasive brain stimulation systems for both therapeutic and diagnostic applications, announces that Aarhus University Hospital, Denmark…

Read more

Nexstim Plc appoints Hanna Kotola as VP of Legal Affairs

News
- 24/04/2017

Helsinki, Finland: 24 April 2017 - Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company developing and marketing pioneering navigated non-invasive brain stimulation systems for both therapeutic (NBT® system) and diagnostic (NBS system) applications, announces the…

Read more

Bluebee Appoints two Independent Board Members

News
- 20/04/2017

Boston MA, USA and Rijswijk, The Netherlands: 20 April 2017 - Bluebee Holding BV a leading provider of high performance genomics solutions, today announced the appointment of two new members to its Board of Directors.…

Read more

Avantium announces partial exercise of over-allotment option bringing the gross proceeds of its Initial Public Offering to € 109 million

News
- 13/04/2017

Amsterdam, the Netherlands: 13 April 2017 - Avantium N.V., a leading chemical technology company and forerunner in renewable chemistry, today announces that the Joint Global Coordinators, on behalf of the underwriters, have partially exercised the…

Read more

GreenFlame Heats Up Ahead of Grilling Season

News
- 11/04/2017

Ashland, Virginia and Abingdon, UK: 11 April 2017 - Green Biologics, Inc., the US subsidiary of Green Biologics Ltd., a UK industrial biotechnology and renewable specialty chemicals company, announced today growing retail interest in and…

Read more

Astellas to acquire Ogeda SA Copy

News
- 02/04/2017

Tokyo, Japan, and Gosselies, Belgium: 2 April 2017 - Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka) and Ogeda SA (CEOFJean Combalbert) announced today that Astellas and Ogeda shareholders have entered into a…

Read more

Astellas to acquire Ogeda SA

News
- 02/04/2017

Tokyo, Japan, and Gosselies, Belgium: 2 April 2017 - Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka) and Ogeda SA (CEOFJean Combalbert) announced today that Astellas and Ogeda shareholders have entered into a…

Read more

Mainstay Medical Publishes 2016 Full Year Results and Business Update

News
- 23/03/2017

23 March 2017 - Mainstay Medical International plc (Euronext Paris: MSTY.PA and ESM of the Irish Stock Exchange: MSTY.IE), a medical device company focused on bringing to market ReActiv8®, an implantable restorative neurostimulation system to…

Read more

Nexstim Plc signs an Independent Selling Representative Agreement in the US with JTec Surgical

News
- 22/03/2017

Helsinki, Finland: 22 March 2017 - Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company with a pioneering navigated non-invasive brain stimulation system, announces that its wholly owned subsidiary Nexstim Inc. has signed a new Independent…

Read more

Avantium raises € 103 million in successful Initial Public Offering

News
- 14/03/2017

Amsterdam, the Netherlands: 14 March 2017 - Avantium Holding B.V., a leading chemical technology company and forerunner in renewable chemistry, today announces the results of its initial public offering on Euronext Amsterdam and Euronext Brussels.…

Read more

FRX Polymers achieves ISO 9001:2015 Certification

News
- 09/03/2017

Chelmsford, MA, USA: 9 March 2017 - FRX Polymers, Inc (FRX), the global leader in polymeric halogen-free flame retardant solutions, has earned ISO 9001:2015 certification from the International Organization for Standardization (ISO), effective February 6.…

Read more

Nexstim Plc announces signing of an Independent Selling Representative Agreement in the US with Surgical Solutions, Inc

News
- 08/03/2017

Helsinki, Finland: 8 March 2017 - Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company with a pioneering navigated non-invasive brain stimulation system, announces that its wholly owned subsidiary Nexstim Inc. has signed a new Independent…

Read more

Nexstim Plc announces the start of patient enrolment in the supplementary Phase III Trial in Stroke Rehabilitation with its NBT system

News
- 07/03/2017

Helsinki, Finland: 7 March 2017 - Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company with a pioneering navigated non-invasive brain stimulation system (NBT® system), announces that it has enrolled the first patients in its supplemental…

Read more

Avantium launches its initial public offering on Euronext Amsterdam and Euronext Brussels

News
- 06/03/2017

Amsterdam, the Netherlands: 6 March 2017 - Avantium Holding B.V., a leading chemical technology company and forerunner in renewable chemistry, today announces the price per Offer Share of € 11.00 and offer size for, and…

Read more

Trod Medical is mentioned in Medical Device Daily

News
- 24/02/2017

Paris, France: 24 February 2017 - There are often incremental changes to electrosurgical devices, but few true innovations, which may explain the enthusiasm at Trod Medical NV for announcing a new patent. Based in Leuven, Belgium,…

Read more

Trod Medical is mentioned in Medical Device Daily

News
- 24/02/2017

Paris, France: 24 February 2017 - There are often incremental changes to electrosurgical devices, but few true innovations, which may explain the enthusiasm at Trod Medical NV for announcing a new patent. Based in Leuven, Belgium,…

Read more

Jungbunzlauer and Green Biologics Partner on Bio-Based Plasticizers

News
- 14/02/2017

Ashland, USA and Abingdon, UK: 14 February 14 2017 - Green Biologics, Inc., the US subsidiary of Green Biologics Ltd., a UK industrial biotechnology and renewable chemicals company, announced today an exclusive collaboration with Jungbunzlauer…

Read more

Avantium announces intention to launch Initial Public Offering and listing on Euronext Amsterdam and Euronext Brussels

News
- 13/02/2017

Amsterdam, the Netherlands: 13 February 2017 - Avantium Holding BV, a leading chemical technology company and forerunner in renewable chemistry, today announces its intention to raise new funds through an Initial Public Offering and listing…

Read more

Partnership initiated for the development of a Wood to Chemicals Reference Plant in Delfzijl

News
- 09/02/2017

Amsterdam, the Netherlands: 9 February 2017 - Avantium, a leading chemical technology company and forerunner in renewable chemistry, announces a partnership with AkzoNobel, Chemport Europe, RWE and Staatsbosbeheer for the development of a reference plant…

Read more

Mainstay Medical starts commercialization of ReActiv8® for the treatment of Chronic Low Back Pain

News
- 01/02/2017

Dublin, Ireland: 1 February 2017 - Mainstay Medical International plc (Euronext Paris: MSTY.PA and ESM of the Irish Stock Exchange: MSTY.IE), a medical device company focused on bringing to market ReActiv8®, an implantable neurostimulation system…

Read more

Confo Therapeutics is awarded € 2.6 million in non-dilutive funding for the discovery of new fibrosis treatments and for expanding the use of its unique Confo® technology

News
- 01/02/2017

Ghent, Belgium: 1 February 2017 - Confo Therapeutics, an emerging drug discovery company, today announced that it has received a €1.6 million grant from Flanders Innovation & Entrepreneurship (VLAIO). Confo Therapeutics will use the grant,…

Read more

Neurosurgeons from Germany and USA report on their clinical experience of using Nexstim NBS system

News
- 31/01/2017

Helsinki, Finland: 31 January 2017 - Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company with a pioneering navigated non-invasive brain stimulation system, announces that, in a recently published clinical article, neurosurgeons report clinical benefits of…

Read more

Green Biologics acquires GreenFlame™ Brand, Inks Kroger as first retail partner for sustainable charcoal lighter fluid

News
- 31/01/2017

Ashland, USA and Abingdon, UK: 31 January 2017 - Green Biologics, Inc, the US subsidiary of Green Biologics Ltd, a UK industrial biotechnology and renewable chemicals company, today announces the acquisition of the GreenFlameTM brand…

Read more

Avantium in the 2017 Global Cleantech 100

News
- 24/01/2017

Amsterdam, the Netherlands: 24 January 2017 - Avantium, a leading chemical technology company and forerunner in renewable chemistry, today announced it was named in the prestigious 2017 Global Cleantech 100, produced by CTG (Cleantech Group), whose…

Read more

EpiGaN is Named among the 2017 Global Cleantech 100

News
- 24/01/2017

Hasselt, Belgium: 24 January 2017 - EpiGaN, a leading provider of III-nitride semiconductor material solutions for efficient power systems, is listed again among the prestigious 2017 Global Cleantech 100, produced by the Cleantech Group. CTGkeeps…

Read more

Mainstay confirms its continued eligibility to the PEA-PME

News
- 24/01/2017

Dublin, Ireland: 24 January 2017 - Mainstay Medical International plc (listed on Euronext Paris: MSTY.PA and ESM of the Irish Stock Exchange: MSTY.IE) confirms today its continued eligibility to the PEA-PME (French equity savings plan…

Read more

Mainstay Medical Applies for Approval to Market ReActiv8® in Australia

News
- 12/01/2017

Dublin, Ireland: 12 January 2017 - Mainstay Medical International plc (Euronext Paris: MSTY.PA and ESM of the Irish Stock Exchange: MSTY.IE), a medical device company focused on bringing to market ReActiv8, an implantable neurostimulation system…

Read more

NGDATA closes additional $9.4 million Series B Round for next generation Customer Experience Management

News
- 05/01/2017

New York, USA: 5 January 2017 - NGDATA®, the customer experience management solutions company, today announced that it has closed US$ 9.4 million of venture funding, bringing the total Series B round to roughly US$…

Read more

Nexstim to present at Biotech Showcase 9th Annual Conference in San Francisco

News
- 05/01/2017

Helsinki, Finland: 5 January 2017 - Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company with a pioneering navigated non-invasive brain stimulation system, today announces that Chairman of the Board and Chief Executive Officer, Martin Jamieson,…

Read more

LindaCare expands its operations to the USA

News
- 04/01/2017

Leuven, Belgium: 4 January 2017 - LindaCare, a software company specializing in the field of remote patient monitoring solutions for chronic disease patients, has announced that it will open a new customer support facility in…

Read more

Capricorn Venture Partners announces first closing of its Capricorn Sustainable Chemistry Fund (CSCF) at € 50 million

News
- 23/12/2016

Leuven, Belgium: 23 December 2016 - Capricorn Venture Partners is pleased to announce the closing of the 1st round of financing for the Capricorn Sustainable Chemistry Fund (CSCF) at € 50 million, an important milestone…

Read more

Avantium acquires Liquid Light

News
- 21/12/2016

Amsterdam, the Netherlands: 21 December 2016 - Avantium, a leading chemical technology company and forerunner in renewable chemistry announced today it has acquired the assets of Liquid Light Inc. (Liquid Light) a renowned developer of…

Read more

Ogeda announces fezolinetant as INN and issuance of US patent for ESN364

News
- 20/12/2016

Gosselies, Belgium: 20 December 2016 - Ogeda, a clinical-stage drug discovery company that invents and develops small molecule drug candidates targeting G-protein coupled receptors (GPCRs), announces today that the World Health Organization (WHO) has recommended…

Read more

Indigo announces successful Series A financing round

News
- 19/12/2016

Ghent, Belgium: 19 December 2016 - Indigo Diabetes nv (Indigo), a spin-off from Ghent University (UGent) and imec, today announces the successful closure of a 7 million Euros series-A financing round. The funding is provided…

Read more

Michiel Boersma appointed as Chairman of Avantium’s Supervisory Board

News
- 15/12/2016

Amsterdam, the Netherlands: 15 December 2016 - Avantium, a leading chemical technology company and forerunner in renewable chemistry, announces the appointment of Michiel Boersma as Chairman of its Supervisory Board. Michiel Boersma succeeds Jan van…

Read more

Confo Therapeutics to appoint John Berriman as Chairman of the Board

News
- 15/12/2016

Brussels, Belgium: 15 December 2016 - Confo Therapeutics, an emerging drug discovery company, today announced the appointment of John Edward Berriman as non-executive director and chairman of the board of directors, starting December 21. Commenting…

Read more

Bluebee achieves HIPAA compliance

News
- 14/12/2016

Boston MA, USA and Rijswijk, The Netherland: 14 December 2016 - Bluebee, a leading provider of high performance genomics solutions, announced today that the company has achieved compliance with all data security safeguards outlined in…

Read more

Green Biologics begins customer shipments at first commercial plant

News
- 13/12/2016

Ashland, USA and Abingdon, UK: 13 December 2016 - Green Biologics Ltd, a UK industrial biotechnology and renewable specialty chemicals company, announced today the start of commercial shipments of bio-based n-butanol and acetone from its…

Read more

Bio-based Companies Rank in Global Cleantech 100

News
- 15/10/2014

Leuven, Belgium: 15 October 2014 - Three Capricorn Venture Partners cleantech companies were recognised in the distinguished Global Cleantech 100 list. The three companies were among a number of bio-based organisations, clearly demonstrating the power…

Read more
More related content